The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Abstract
Objective. —To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD). Design. —Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD. Setting. —Convents in the Midwestern, Eastern, and Southern United States. Participants. —A total of 102 college-educated women aged 76 to 100 years. Main Outcome Measures. —Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria. Results. —Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7,95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts. Conclusion. —These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
In the citing paper
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
In the citing paper
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
In the citing paper
“typically are accompanied by Alzheimer disease and other pathologies.”
In the citing paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
In the citing paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
In the citing paper
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
In the citing paper
“Lacunes are frequently seen on imaging in elderly patients with no symptoms”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“are associated with an increased risk of stroke, gait impairment, and dementia.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“Cerebrovascular effects of APOE4 are associated with AD, stroke, and brain hemorrhage (314, 506, 549, 614, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [549]
In the citing paper
“Classical anatomic locations for strategic infarcts include the thalamus, angular gyrus, and basal ganglia, including the caudate nucleus and globus pallidus. 52-57”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“A single small infarct may cause severe cognitive deficits when located in a strategic brain region.”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [19]
In the citing paper
“On the other hand, in older individuals with moderate AD pathology subcortical vascular lesions are a major determinant of the expression of the dementia (Esiri et al., 1999; Schneider et al., 2007b; Snowdon et al., 1997).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Snowdon et al., 1997
In the citing paper
“it seems reasonable to postulate that insulin resistance and T2D could increase AD risk through cerebrovascular disease, a factor increasingly accepted to be important in AD manifestation [5, 19-21].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [5]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 1,001–1,100 of 1,644
Treatment options for renovascular hypertension
Spence, J. D. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.4.411 · Cited by 21
Therapeutic Issues in Vascular Dementia: Studies, Designs and Approaches
Black, S. E. (2007) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100005692 · Cited by 22
Cholinesterase Inhibitors and Vascular Dementia
Bullock, R. A. (2004) · CNS Drugs · doi:10.2165/00023210-200418020-00002 · Cited by 21
Mandell, A. M., & Green, R. C. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch1 · Cited by 22
Elder, G. A., Cho, J. Y., English, D. F., Franciosi, S., Schmeidler, J., Sosa, M. A. G., Gasperi, R. D., Fisher, E. A., Mathews, P. M., Haroutunian, V., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04614.x · Cited by 26
Neuropathological Profile of Mild Cognitive Impairment From a Population Perspective
Stephan, B. C. M., Matthews, F. E., Hunter, S., Savva, G. M., Bond, J., McKeith, I. G., Ince, P. G., & Brayne, C. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31822fc24d · Cited by 22
Neuropsychological assessment and cerebral vascular disease: The new standards
Godefroy, O., Leclercq, C., Bugnicourt, J., Roussel, M., Moroni, C., Quaglino, V., Beaunieux, H., Taillia, H., Nédélec-Ciceri, C., Bonnin, C. A., et al. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.009 · Cited by 20
The dance of communication: Retaining family membership despite severe non-speech dementia
Walmsley, B. D., & McCormack, L. (2013) · Dementia · doi:10.1177/1471301213480359 · Cited by 20
Ha, S.-Y., Youn, Y. C., Kim, S., Hsiung, G. R., Ahn, S.-W., Shin, H., Park, K., Park, T. H., Kim, S.-S., Kee, B. S., et al. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.11.041 · Cited by 20
The Role of Cardiovascular Risk Factors in Alzheimer's Disease
Ravona‐Springer, R., Davidson, M., & Noy, S. (2003) · CNS Spectrums · doi:10.1017/s109285290001926x · Cited by 20
Levit, A., Regis, A. M., Garabon, J. R., Oh, S., Desai, S. J., Rajakumar, N., Hachinski, V., Ağca, Y., Agca, C., Whitehead, S. N., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.006 · Cited by 21
Clinical implications of extracellular vesicles in neurodegenerative diseases
Vinaiphat, A., & Sze, S. K. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1657407 · Cited by 20
Mixed Brain Pathology Is the Most Common Cause of Cognitive Impairment in the Elderly
Alafuzoff, I. I., & Libard, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200925 · Cited by 21
Merino, J. G., & Hachinski, V. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0007-5 · Cited by 20
Logue, M. W., Posner, H. B., Green, R. C., Moline, M. L., Cupples, L. A., Lunetta, K. L., Zou, H., Hurt, S. W., Farrer, L. A., DeCarli, C. S., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.01.004 · Cited by 22
Yang, J., d’Esterre, C. D., Ceruti, S., Roversi, G., Saletti, A., Fainardi, E., & Lee, T. (2015) · BMC Neurology · doi:10.1186/s12883-015-0468-0 · Cited by 20
Vascular disease and cognitive impairment
Reitz, C., Luchsinger, J. A., & Mayeux, R. P. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.8.1171 · Cited by 20
Alzheimer's Disease and Brain Reserve
Schofield, P. (1999) · Australian Journal on Ageing · doi:10.1111/j.1741-6612.1999.tb00081.x · Cited by 22
Ostwald, S. K., Godwin, K. M., Ye, F., & Cron, S. G. (2013) · Rehabilitation Nursing · doi:10.1002/rnj.87 · Cited by 19
GJ-4 alleviates Aβ25-35-induced memory dysfunction in mice through protecting the neurovascular unit
Zhang, Z., Liu, H., Zhao, Z., Zang, C., Ju, C., Li, F., Wang, L., Yang, H., Bao, X., Yu, Y., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110131 · Cited by 19
Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins
Ułamek-Kozioł, M., Pluta, R. M., Bogucka‐Kocka, A., Januszewski, S., Kocki, J., & Czuczwar, S. J. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.01.006 · Cited by 19
Loss of corneal nerves and brain volume in mild cognitive impairment and dementia
Ponirakis, G., Hamad, H. K. A., Khan, A., Petropoulos, I. N., Gad, H., Chandran, M., Elsotouhy, A., Ramadan, M., Gawhale, P. V., Elorrabi, M., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12269 · Cited by 19
Aerobic exercise reverses aging-induced depth-dependent decline in cerebral microcirculation
Shin, P., Pian, Q., Ishikawa, H., Hamanaka, G., Mandeville, E. T., Guo, S., Fu, B., Alfadhel, M. A. H., Allu, S., Şencan, İ., et al. (2023) · eLife · doi:10.7554/elife.86329 · Cited by 22
The Relationship between Amyloid Deposition, Neurodegeneration, and Cognitive Decline in Dementia
Vandenberghe, R. R. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0498-9 · Cited by 21
Imaging of Cerebral Amyloid Angiopathy with Bivalent 99mTc-Hydroxamamide Complexes
Iikuni, S., Ono, M., Watanabe, H., Matsumura, K., Yoshimura, M., Kimura, H., Ishibashi‐Ueda, H., Okamoto, Y., Ihara, M., & Saji, H. (2016) · Scientific Reports · doi:10.1038/srep25990 · Cited by 19
The Role of B Group Vitamins and Choline in Cognition and Brain Aging
Bonetti, F., Brombo, G., & Zuliani, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805376-8.00015-0 · Cited by 20
Mitchell, C., Wilbrand, S. M., Kundu, B., Steffel, C. N., Varghese, T., Meshram, N. H., Li, G., Cook, T. D., Salamat, M. S., & Dempsey, R. J. (2017) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2017.04.025 · Cited by 19
Actual Conditions of Leisure Activity Among Older Community-Dwelling Japanese Adults
Iwasa, H., & Yoshida, Y. (2018) · Gerontology and Geriatric Medicine · doi:10.1177/2333721418781677 · Cited by 21
Vidal, C., & Li, Z. (2021) · Cells · doi:10.3390/cells10030546 · Cited by 20
Statins and brain integrity in older adults: Secondary analysis of the Health ABC study
Nadkarni, N. K., Perera, S., Hanlon, J. T., López, O. L., Newman, A. B., Aizenstein, H. J., Elam, M. B., Harris, T. B., Kritchevsky, S. B., Yaffe, K. S., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.11.003 · Cited by 19
Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients
Baran, H., Hainfellner, J. A., & Kepplinger, B. (2012) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s10627 · Cited by 19
Skoog, I. G. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203009104 · Cited by 19
Clarke, R., Joachim, C. L., Esiri, M. M., Morris, J. R., Bungay, H. K., Molyneux, A., Budge, M. M., Frost, C. D., KING, E., Barnetson, L. P. D., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06405.x · Cited by 19
Vascular Cognitive Impairment and Dementia
Martínez‐Lage, P., & Hachinski, V. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_73 · Cited by 18
AD and non‐AD mediators of the pathway between the APOE genotype and cognition
Nichols, E., Brickman, A. M., Casaletto, K. B., Dams-O’Connor, K., George, K. M., Kumar, R. G., Palta, P., Rabin, J. S., Satizábal, C. L., Schneider, J. A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12885 · Cited by 18
Activated Microglia in Alzheimer’s Disease and Stroke
Pocock, J. M., Liddle, A. C., Hooper, C., Taylor, D. L., Davenport, C. M., & Morgan, S. (2002) · Springer eBooks · doi:10.1007/978-3-662-05073-6_7 · Cited by 17
Cooper, S., CASLAKE, M. J., Evans, J. J., Hassiotis, A., Jahoda, A. J., McConnachie, A., Morrison, J., RING, H. A., Starr, J. M., Stiles, C., et al. (2014) · Trials · doi:10.1186/1745-6215-15-202 · Cited by 18
Vascular Contributions to Cognitive Impairment in Late Life
Chui, H. C., & Gomez, L. A. R. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.007 · Cited by 19
Blumenau, S., Foddis, M., Müller, S., Holtgrewe, M., Bentele, K., Berchtold, D., Beule, D., Dirnagl, U., & Sassi, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63183-5 · Cited by 19
Physiological and Pathological Functions of Beta-Amyloid in the Brain and Alzheimer'S Disease
Volicer, L. (2020) · The Chinese Journal of Physiology · doi:10.4103/cjp.cjp_10_20 · Cited by 18
O’Neill, R. A., Maxwell, A. P., Paterson, E., Kee, F., Young, I. S., Hogg, R. E., Cruise, S. M., Murphy, S., McGuinness, B., & McKay, G. J. (2021) · BMC Neurology · doi:10.1186/s12883-021-02137-4 · Cited by 18
Blackburn, D. J., Krishnan, K., Fox, L., Ballard, C. G., Burns, A. S., Ford, G. A., Mant, J., Passmore, P., Pocock, S., Reckless, J. P. D., et al. (2013) · Trials · doi:10.1186/1745-6215-14-401 · Cited by 19
Mortimer, J. A., Snowdon, D. A., & Markesbery, W. R. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318170d455 · Cited by 18
Self-citationAlzheimer Pathology in Elderly Patients With Glioblastoma Multiforme
Nelson, J. S. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1515-apiepw · Cited by 18
Is pharmacological prevention of Alzheimer's a realistic goal?
Anthony, J. C., Breitner, J. C. S., & Zandi, P. P. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.4.365 · Cited by 18
Shityakov, S., Hayashi, K., Störk, S., Scheper, V., Lenarz, T., & Förster, C. Y. (2021) · Biomolecules · doi:10.3390/biom11060900 · Cited by 18
Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?
Ravona-Springer, R., Davidson, M., & Noy, S. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.1/rravonaspringer · Cited by 18
Carotid intima-media thickness and cognitive decline: what does it mean for prevention of dementia?
Spence, J. D. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.05.012 · Cited by 18
Rossi, R., Joachim, C. L., Smith, A. D., & Frisoni, G. B. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1132 · Cited by 18
Vollhardt, A., Frölich, L., Stockbauer, A., Danek, A., Schmitz, C., & Wahl, A.-S. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106845 · Cited by 18
Combined Alzheimer's disease and cerebrovascular staging explains advanced dementia cognition
Zea‐Sevilla, M. A., Fernández‐Blázquez, M. A., Calero, M., Velasco, P. E. B., & Rábano, A. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.01.004 · Cited by 17
Advanced Asymptomatic Carotid Disease and Cognitive Impairment: An Understated Link?
Martinić-Popović, I., Lovrenčić‐Huzjan, A., & Demarin, V. (2012) · Stroke Research and Treatment · doi:10.1155/2012/981416 · Cited by 17
Diagnostic Utility of Cerebral White Matter Integrity in Early Alzheimer's Disease
Johnson, D. K., Barrow, W., Anderson, R. E., Harsha, A., Honea, R. A., Brooks, W. M., & Burns, J. M. (2010) · International Journal of Neuroscience · doi:10.3109/00207454.2010.494788 · Cited by 19
Evaluation of aging vs dementia by means of neurosonology
Demarin, V., Kes, V. B., Morović, S., & Zavoreo, I. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.006 · Cited by 17
Zhuang, S., Li, J., Wang, X., Wang, H., Zhang, W., Wang, H., & Xing, C.-M. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.011 · Cited by 18
Yue, W., Wang, A., Liang, H., Hu, F., Zhang, Y., Deng, M., Li, T., Hu, X. F., Ye, Z., Shen, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep19556 · Cited by 17
Factors of post‐stroke dementia: A nationwide cohort study in Taiwan
Li, C., Chang, Y., Chou, M., Chen, C., Ho, B., Hsieh, S., & Yang, Y. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13725 · Cited by 16
Sasahara, T., Satomura, K., Tada, M., Kakita, A., & Hoshi, M. M. (2021) · iScience · doi:10.1016/j.isci.2021.102936 · Cited by 17
Kantarovich, K., Mwilambwe-Tshilobo, L., Fernández‐Cabello, S., Setton, R., Baracchini, G., Lockrow, A. W., Spreng, R. N., & Turner, G. R. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.01.005 · Cited by 16
Clinical-pathologic correlations in vascular cognitive impairment and dementia
Flanagan, M. E., Larson, E. B., Latimer, C. S., Cholerton, B., Crane, P. K., Montine, K. S., White, L. R., Keene, C. D., & Montine, T. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.019 · Cited by 17
Ortner, M., Kurz, A., Alexopoulos, P., Auer, F., Diehl-Schmid, J., Drzezga, A., Förster, S., Förstl, H., Perneczky, R., Sorg, C., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.019 · Cited by 17
Adunsky, A., Chesnin, V., Davidson, M., Gerber, Y., Alexander, K., & Haratz, D. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.11.m757 · Cited by 17
Vascular complications in dementia with Lewy bodies: A postmortem study
Isojima, D., Togo, T., Kosaka, K., Fujishiro, H., Akatsu, H., Katsuse, O., Iritani, S., Matsumoto, T., & Hirayasu, Y. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00699.x · Cited by 17
McNeal, D. W., Brandner, D. D., Gong, X., Postupna, N. O., Montine, T. J., Keene, C. D., & Back, S. A. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw032 · Cited by 17
Autonomic Cardiac Function in Preclinical Alzheimer’s Disease
Santos, C. Y., Machan, J. T., Wu, W., & Snyder, P. J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170217 · Cited by 17
White matter abnormalities and cognition in patients with conflicting diagnoses and CSF profiles
Lindemer, E., Greve, D. N., Fischl, B. R., Salat, D. H., & Gómez‐Isla, T. (2018) · Neurology · doi:10.1212/wnl.0000000000005353 · Cited by 16
Serum Level and Activity of Butylcholinesterase: A Biomarker for Post-Stroke Dementia
Chen, Y., Chou, W., Fang, C., Liu, T., Tsou, H., Wang, Y., & Liu, Y. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111778 · Cited by 19
Goo, M., Choi, S. M., Kim, S.-H., & Ahn, B. O. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0116-9 · Cited by 17
Desmond, D. W. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.04.009 · Cited by 17
Cerebrovascular lesions in elderly Japanese patients with Alzheimer's disease
Nagata, K., Takano, D., Yamazaki, T., Maeda, T., Satoh, Y., Nakase, T., & Ikeda, Y. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.001 · Cited by 16
Pluta, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813793 · Cited by 13
Kim, J. N., Schweizer, T. A., Fischer, C. E., & Muñoz, D. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160506 · Cited by 16
Scott, T. M., Bhadelia, R. A., Qiu, W. Q., Folstein, M. F., & Rosenberg, I. H. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180366 · Cited by 16
Molecular Genetics of Familial Alzheimer Disease
Shastry, B. S. (1998) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40324-6 · Cited by 16
Endovascular middle cerebral artery occlusion in rats as a model for studying vascular dementia
Yang, S., Shetty, R. A., Liu, R., Sumien, N., Heinrich, K. R., Rutledge, M. A., Thangthaeng, N., Brun‐Zinkernagel, A., & Forster, M. J. (2006) · AGE · doi:10.1007/s11357-006-9026-4 · Cited by 16
Angiotensin-converting enzyme gene and plasma protein level in Alzheimer's disease in Taiwanese
Yang, Y., Lai, C.-L., Tyan, Y., Chou, M., Wang, L., Yang, M., & Liu, C.-K. (2011) · Age and Ageing · doi:10.1093/ageing/afq179 · Cited by 16
Cognitive Pharmacotherapy of Alzheimer's Disease and other Dementias
Herrmann, N. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700802 · Cited by 16
Hagnelius, N.-O., Boman, K., & Nilsson, T. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.10.001 · Cited by 16
Ouyang, F., Chen, X., Chen, Y., Liang, J., Chen, Y., Lu, T., Huang, W., & Zeng, J. (2019) · Brain Pathology · doi:10.1111/bpa.12764 · Cited by 16
Pathological Lesions in Vascular Dementia
Pantoni, L., Palumbo, V., & Sarti, C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04827.x · Cited by 16
The Cerebrovascular Pathology in Alzheimer's Disease and Its Influence on Clinical Variables
Modrego, P. J., Ríos, C., Trullén, J. M. P., Errea, J. M., García-Gómara, M. J., & Sanchez, S. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507309274 · Cited by 16
Pharmacogenomics in cardiovascular diseases
Mukherjee, D., & Topol, E. J. (2003) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2003.09.002 · Cited by 16
Buckwalter, M. S., Pepper, J., Gaertner, R., Euw, D. V., Lacombe, P. M., & Wyss‐Coray, T. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04801.x · Cited by 17
Sharma, M., Hart, R. G., Smith, E. E., Bosch, J., Yuan, F., Casanova, A., Eikelboom, J. W., Connolly, S. J., Wong, G. C., Díaz, R., et al. (2018) · International Journal of Stroke · doi:10.1177/1747493018784478 · Cited by 15
Glans, I., Nägga, K., Gustavsson, A., Stomrud, E., Nilsson, P. M., Melander, O., Hansson, O., & Palmqvist, S. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01497-6 · Cited by 16
Pinto, L. D., Puppin, P. A. L., Behring, V. M., Alves, O. C., Rey, N. A., & Felcman, J. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.01.025 · Cited by 15
Kemppainen, S., Hämäläinen, E., Miettinen, P. O., Koıstınaho, J., & Tanila, H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.050 · Cited by 15
Central Nervous System Correlates of “Objective” Neuropathy in Alcohol Use Disorder
Zahr, N. M., Pohl, K. M., Pfefferbaum, A., & Sullivan, E. V. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14162 · Cited by 15
Lamar, M., Zhou, X. J., Charlton, R. A., Dean, D., Little, D. M., & Deoni, S. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.08.001 · Cited by 16
Differential effects of angiotensin II receptor blockers on Aβ generation
Liu, J., Liu, S., Tanabe, C., Maeda, T., Zou, K., & Komano, H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.03.030 · Cited by 16
Vascular cognitive impairment (VCI): Progress towards knowledge and treatment
Legge, S. D., & Hachinski, V. (2010) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642010dn40100002 · Cited by 15
Price, C. C., Tanner, J. J., Schmalfuss, I. M., Brumback, B., Heilman, K. M., & Libon, D. J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150407 · Cited by 15
Ezzati, A., Wang, C., Lipton, R. B., Altschul, D., Katz, M. J., Dickson, D. W., & Derby, C. A. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14903 · Cited by 15
How proteomics reveals potential biomarkers in brain diseases
Schmidt, O., Schulenborg, T., Meyer, H. E., Marcus, K., & Hamacher, M. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.6.901 · Cited by 16
Drug Candidates for the Treatment of Alzheimer’s Disease: New Findings from 2021 and 2022
Motebennur, S. L., Nandeshwarappa, B. P., & Katagi, M. S. (2023) · Drugs and Drug Candidates · doi:10.3390/ddc2030030 · Cited by 14
Atypical clinical variants of Alzheimer’s disease: are they really atypical?
Whitwell, J. L. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1352822 · Cited by 15
Current Management Decisions in Mild Cognitive Impairment
Bensadon, B. A., & Odenheimer, G. L. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.008 · Cited by 14
Ciolli, L., Poggesi, A., Salvadori, E., Valenti, R., Nannucci, S., Pasi, M., Pescini, F., Inzitari, D., & Pantoni, L. (2012) · Neurological Sciences · doi:10.1007/s10072-012-0941-0 · Cited by 14
Yang, J., d’Esterre, C. D., Amtul, Z., Cechetto, D. F., & Lee, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100575 · Cited by 14
Moderate dementia: relational social engagement (RSE) during family visits
Walmsley, B. D., & McCormack, L. (2017) · Aging & Mental Health · doi:10.1080/13607863.2017.1326462 · Cited by 14
Metadata
- Authors
- Snowdon, D. A.
- Corresponding author
- Snowdon, David A.
- ORCID
- Snowdon, David A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4296588155
- Cited by
- 1,590
- References
- 0
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 30 · 2023: 39 · 2022: 43 · 2021: 42 · 2020: 51 · 2019: 57 · 2018: 52 · 2017: 60 · 2016: 74 · 2015: 63 · 2014: 71 · 2013: 61 · 2012: 74
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Funders
- National Institute on Aging (R01AG009862, P50AG005144, KO4AG00553)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebral infarction, lacunar infarction, dementia, cognitive function, amyloid plaques, neurofibrillary tangles, cerebrovascular disease, atherosclerosis, circle of Willis, thalamic infarction, basal ganglia infarcts, older women, neuropathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
